Medtronic Perfusion Systems: FDA filings under this applicant name
FDA lists 29 510(k) clearances under the applicant name “Medtronic Perfusion Systems” (first 2000, latest 2024), across 12 product codes in 3 review panels. Median 510(k) review time under this name: 36 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Medtronic, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 1 | 139 |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 1 | 30 |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 1 | 124 |
| 2025 | 0 | — |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Medtronic Perfusion Systems took a median 77 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 141 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| DWF | Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass | 12 | 12 |
| DTM | Filter, Blood, Cardiopulmonary Bypass, Arterial Line | 4 | 4 |
| DTN | Reservoir, Blood, Cardiopulmonary Bypass | 2 | 2 |
| DWA | Control, Pump Speed, Cardiopulmonary Bypass | 2 | 2 |
| FMF | Syringe, Piston | 2 | 2 |
| CAC | Apparatus, Autotransfusion | 1 | 1 |
| DPT | Probe, Blood-Flow, Extravascular | 1 | 1 |
| DRY | Monitor, Blood-Gas, On-Line, Cardiopulmonary Bypass | 1 | 1 |
| DTP | Defoamer, Cardiopulmonary Bypass | 1 | 1 |
| DTZ | Oxygenator, Cardiopulmonary Bypass | 1 | 1 |
Plus 2 more product codes.
Review panels
- Cardiovascular (26)
- General Hospital (2)
- Hematology (1)
Most recent Medtronic Perfusion Systems 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K240666 | Affinity Fusion Oxygenator with Integrated Arterial Filter and Balance Biosurface (BB811); Affinity Fusion Oxygenator with Integrated Arterial Filter and Cardiotomy/Venous Reservoir with Balance Biosurface (BB841); Affinity Fusion Oxygenator with Integrated Arterial Filter and Balance Biosurface NON STERILE (BB811-NS) | DTZ | 2024-07-10 | 124 |
| K181954 | autoLog IQ Autotransfusion System | CAC | 2018-08-22 | 30 |
| K123351 | AFFINITY AF100 ARTERIAL FILTER WITH CARMEDA BIOACTIVE SURFACE | DTM | 2013-03-19 | 139 |
| K101186 | AFFINITY VARD SUB-ASSEMBLY FOR CPS (CARMEDA COATED), PURGELINE (UNCOATED), HOLDING BAG | DTP | 2010-09-03 | 128 |
| K090869 | MIRCSP (MINIMALLY INVASIVE RETROGRADE CORONARY SINUS PERFUSION) MANUAL INFLATE CANNULA, MODEL 94113TD | DWF | 2009-08-27 | 149 |
| K080824 | BIO-CONSOLE 560 | DWA | 2008-05-07 | 44 |
| K061254 | EOPA 3D ARTERIAL CANNULA, MODELS 78220,78222,78320,783222 | DWF | 2006-06-23 | 50 |
| K052524 | BIO-MEDICUS MULTI-STAGE VENOUS FEMORAL PERCUTANEOUS KIT | DWF | 2005-11-22 | 69 |
| K052372 | MC2X MULTI-STAGE VENOUS CANNULA, MODELS 91437, 91437C | DWF | 2005-09-22 | 23 |
| K051303 | BIO-CONSOLE, MODEL 560 | DWA | 2005-06-10 | 22 |
19 earlier clearances. See the full list in Caduvo.
Recalls
141 product recalls in 49 recall events; 55 initiated in the last five years. Most recent: 2026-06-24.
3 product recalls in 2 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: Medtronic Inc. Cardiac Rhythm Disease Management (2), Medtronic Cardiovascular Revascularization & Surgical Therap (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Parent company SEC filings
Medtronic plc (MDT): EDGAR filings, CIK 1613103. Caduvo groups Medtronic Perfusion Systems under Medtronic; the parent's SEC registrant is entered by hand for the group, not matched by name.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Medtronic Vascular (480 510(k)s)
- Medtronic Sofamor Danek (253 510(k)s)
- Medtronic, Inc. (249 510(k)s)
- Medtronic Sofamor Danek USA, Inc. (185 510(k)s)
- Medtronic Minimed (57 510(k)s)
- Medtronic Xomed, Inc. (47 510(k)s)
- Medtronic Navigation, Inc. (45 510(k)s)
- Medtronic Neurosurgery (27 510(k)s)
- Medtronic Blood Systems, Inc. (15 510(k)s)
- Medtronic PS Medical (14 510(k)s)
- Medtronic Ave, Inc. (13 510(k)s)
- Medtronic Bio-Medicus, Inc. (13 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Medtronic Perfusion Systems?
FDA lists 29 510(k) clearances under the applicant name “Medtronic Perfusion Systems” (first 2000, latest 2024), across 12 product codes in 3 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Medtronic Perfusion Systems?
The median time from FDA receipt to decision across 510(k)s cleared under the name Medtronic Perfusion Systems is 36 days.
Which FDA product codes appear under Medtronic Perfusion Systems?
The most frequent FDA product codes under this applicant name are DWF (Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass, 12); DTM (Filter, Blood, Cardiopulmonary Bypass, Arterial Line, 4); DTN (Reservoir, Blood, Cardiopulmonary Bypass, 2).
Next steps
- See all 29 Medtronic Perfusion Systems clearances with predicates and recalls
- Run predicate analysis for product code DWF, Medtronic Perfusion Systems's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.